KS to retire in March 2010

[Anonymous]

he is not going anywhere people. no retirement. nothing.

 

[Anonymous]

he is not going anywhere people. no retirement. nothing.

Lets get his review written here on CP for the last 5 years

 

[Anonymous]

ATO rumor late yesterday:

KS is going to retire ):

Did anyone else hear the whispers?

he is in tight

Director Total Compensation 2008

David Baltimore $281,590
Frank J. Biondi, Jr. $327,206
François de Carbonnel $113,206
Jerry D. Choate $277,078
Vance D. Coffman $529,609
Frederick W. Gluck $314,174
Frank C. Herringer $357,790
Gilbert S. Omenn $304,174
Judith C. Pelham $297,141
J. Paul Reason $273,391
Leonard D. Schaeffer $300,891

Not bad for a few days work a year. Disgraceful.

 

[Anonymous]

ATO rumor late yesterday:

KS is going to retire ):

Did anyone else hear the whispers?

two years later and 17 billion in outstanding bond debt?

 

[Anonymous]

i hope this is true

Done

 

[Anonymous]

What a mess

Quote:
Originally Posted by Anonymous
A half dozen messages have been deleted from this thread. Most dealt with the company's market cap now vs when KS became CEO. I guess readers need to do the math themselves. Don't forget the billions in deals and stock buy backs. Today's market cap is $57.2 B.

Quote:
Originally Posted by Anonymous
12 billion in bond debt used to buy back shares over the last 8 years ???


Throw in aquisition costs for Avidia, Kinetix, Immunex, Tularik, Abgenix, Alantos and Ilypsa. That should be about 20 billion more. If I recall, market cap was about 73 billion at the start of the KS era.

 

[Anonymous]

Give Kevin an IR.

Any biotech company with a costly injectable will be sent into the woodchipper as Obama care gets near full initiation. Big medicaid cuts will begin in the spring and hell will begin to unfold.

 

[Anonymous]

Wasn't Kevin a big supporter of Obamacare?

 

[Anonymous]

Wasn't Kevin a big supporter of Obamacare?

Kevin was and is a big supporter of Sharercare.